IP Library Granted Patent US 11,260,220
Granted Patent B2
US 11,260,220 · App. 16/797,382 · Granted Mar 1, 2022

Implantable cochlear system with integrated components and lead characterization

Inventors: Paul R. Mazanec (Ham Lake, MN); Joshua J. Wibben (New Brighton, MN); Timothy J. Earnest (Vadnais Heights, MN)
Assignee: Envoy Medical Corporation
A61N1/0541A61N1/025A61N1/0488A61N1/08A61N1/36038A61N1/36039A61N1/36171A61N1/378A61N1/37217A61N1/37235A61N1/37241A61N1/37247A61N1/37258A61N1/37282G16H40/67H04W4/80H04W12/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,260,220
App. No.
16/797,382
Granted
Mar 1, 2022
Kind
B2
Abstract

Cochlear implant systems can include a signal processor, an implantable battery and/or communication module, and a plurality of conductors coupling the implantable battery and/or communication module and the signal processor. The implantable battery and/or communication module can communicate data and deliver electrical power to the signal processor via the plurality of conductors. The implantable battery and/or communication module can be configured to perform characterization process to determine one or more characteristics of one or more such conductors. Characterization processes can include determining an impedance between two conductors as a function of frequency, determining whether a conductor is intact, and determining an impedance of a given conductor. Some characterization processes include grounding one or more conductors.

Claims (18)

1. A cochlear implant system comprising:

a signal processor configured to receive an input signal and generate a stimulation signal based on the received input signal;

an implantable battery and/or communication module; and

a first lead comprising a first conductor, a second conductor, a third conductor, and a fourth conductor and coupling the signal processor and the implantable battery and/or communication module; wherein

the implantable battery and/or communication module is configured to generate power signals, inverted power signals, data signals, and inverted data signals and communicate the power signals, the inverted power signals, the data signals, and the inverted data signals to the signal processor via the first conductor, the second conductor, the third conductor, and the fourth conductor of the first lead, respectively; and

the implantable battery and/or communication module and/or the signal processor is configured to perform one or more characterization processes to determine one or more characteristics of the first conductor, the second conductor, the third conductor, and/or the fourth conductor.

2. The cochlear implant system of claim 1 , wherein the power signals and the inverted power signals are communicated by the implantable battery and/or communication module at a first clocking rate, the data signals and the inverted data signals are communicated by the implantable battery and/or communication module at a second clocking rate, the second clocking rate being higher than the first clocking rate.

3. The cochlear implant system of claim 2 , wherein performing the one or more characterization processes comprises determining an integrity of the third conductor and/or the fourth conductor.

4. The cochlear implant system of claim 3 , wherein, if the third conductor and/or the fourth conductor is found to be faulty, the implantable battery and/or communication module is configured to communicate the data signals to the signal processor at the first clocking rate via one of the first conductor or the second conductor and communicate the inverted data signals to the signal processor at the first clocking rate via the other of the first conductor and the second conductor.

5. The cochlear implant system of claim 1 , wherein performing the one or more characterization processes comprises grounding one of the first conductor, the second conductor, the third conductor, or the fourth conductor, and applying a test signal to a different one of the first conductor, the second conductor, the third conductor, or the fourth conductor at a plurality of frequencies.

6. The cochlear implant system of claim 5 , wherein performing the one or more characterization processes comprises determining an impedance versus frequency relationship between two conductors, the two conductors being any two conductors selected from the first conductor, the second conductor, the third conductor, and the fourth conductor.

7. The cochlear implant system of claim 1 , wherein performing the one or more characterization processes comprises:

driving a test signal through a test conductor, the test conductor being one of the first conductor, the second conductor, the third conductor, or the fourth conductor;

measuring a current sent through the test conductor; and

measuring a voltage at which the current is sent through the test conductor.

8. The cochlear implant system of claim 7 , wherein performing the one or more characterization processes further comprises determining an impedance of the test conductor.

9. The cochlear implant system of claim 1 , wherein performing the one or more characterization processes comprises measuring one or more electrical parameters of one or more of the first conductor, the second conductor, the third conductor, and the fourth conductor and comparing the one or more measured electrical parameters to a corresponding one or more baseline parameters.

10. The cochlear implant system of claim 9 , wherein the implantable battery and/or communication module is configured to output a measurement value and/or a warning if one or more of the one or more measured electrical parameters deviates from the corresponding one or more baseline parameters by more than a predetermined threshold.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2020
From: MAZANEC, PAUL R.; WHITTINGTON, BENJAMIN R.; EARNEST, TIMOTHY J.; BECKERLE, TRAVIS MICHAEL; WIBBEN, JOSHUA J.
To: ENVOY MEDICAL CORPORATION
Reel/Frame 051890/0733 →
Continuity (2)
Provisional Application 62808634 · Feb 21, 2019
Related Publication 20200269058A1 · Aug 27, 2020